Molecular pathways associated with oxidative stress and their potential applications in radiotherapy (Review)
- Authors:
- Rui Liu
- Yan Bian
- Lin Liu
- Lianchang Liu
- Xiaodong Liu
- Shumei Ma
-
Affiliations: NHC Key Laboratory of Radiobiology, School of Public Health of Jilin University, Changchun, Jilin 130000, P.R. China, Department of Occupational and Environmental Health, School of Public Health and Management, Wenzhou Medical University, Wenzhou, Zhejiang 325000, P.R. China - Published online on: March 15, 2022 https://doi.org/10.3892/ijmm.2022.5121
- Article Number: 65
-
Copyright: © Liu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
 |
|
Zhang Z, Rong L and Li YP: Flaviviridae viruses and oxidative stress: Implications for viral pathogenesis. Oxid Med Cell Longev. 2019:14095822019. | |
|
Pizzino G, Irrera N, Cucinotta M, Pallio G, Mannino F, Arcoraci V, Squadrito F, Altavilla D and Bitto A: Oxidative stress: Harms and benefits for human health. Oxid Med Cell Longev. 2017:84167632017. View Article : Google Scholar : PubMed/NCBI | |
|
Hayes JD, Dinkova-Kostova AT and Tew KD: Oxidative stress in cancer. Cancer Cell. 38:167–197. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Beyfuss K and Hood DA: A systematic review of p53 regulation of oxidative stress in skeletal muscle. Redox Rep. 23:100–117. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Pisoschi AM, Pop A, Iordache F, Stanca L, Predoi G and Serban AI: Oxidative stress mitigation by antioxidants-An overview on their chemistry and influences on health status. Eur J Med Chem. 209:1128912021. View Article : Google Scholar | |
|
Zuo L and Wijegunawardana D: Redox role of ROS and inflammation in pulmonary diseases. Adv Exp Med Biol. 1304:187–204. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Czarnocka W and Karpiński S: Friend or foe? Reactive oxygen species production, scavenging and signaling in plant response to environmental stresses. Free Radic Biol Med. 122:4–20. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Samavarchi Tehrani S, Mahmoodzadeh Hosseini H, Yousefi T, Abolghasemi M, Qujeq D, Maniati M and Amani J: The crosstalk between trace elements with DNA damage response, repair, and oxidative stress in cancer. J Cell Biochem. Oct 30–2018.Epub ahead of print. PubMed/NCBI | |
|
Ping Z, Peng Y, Lang H, Xinyong C, Zhiyi Z, Xiaocheng W, Hong Z and Liang S: Oxidative stress in radiation-induced cardiotoxicity. Oxid Med Cell Longev. 2020:35791432020. View Article : Google Scholar : PubMed/NCBI | |
|
Wang XQ, Wang W, Peng M and Zhang XZ: Free radicals for cancer theranostics. Biomaterials. 266:1204742021. View Article : Google Scholar | |
|
Zhang J, Duan D, Song ZL, Liu T, Hou Y and Fang J: Small molecules regulating reactive oxygen species homeostasis for cancer therapy. Med Res Rev. 41:342–394. 2021. View Article : Google Scholar | |
|
Moloney JN and Cotter TG: ROS signalling in the biology of cancer. Semin Cell Dev Biol. 80:50–64. 2018. View Article : Google Scholar | |
|
Zou Z, Chang H, Li H and Wang S: Induction of reactive oxygen species: An emerging approach for cancer therapy. Apoptosis. 22:1321–1335. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Rodic S and Vincent MD: Reactive oxygen species (ROS) are a key determinant of Cancer's metabolic phenotype. Int J Cancer. 142:440–448. 2018. View Article : Google Scholar | |
|
Wang S, Luo J, Zhang Z, Dong D, Shen Y, Fang Y, Hu L, Liu M, Dai C, Peng S, et al: Iron and magnetic: New research direction of the ferroptosis-based cancer therapy. Am J Cancer Res. 8:1933–1946. 2018.PubMed/NCBI | |
|
Snezhkina AV, Kudryavtseva AV, Kardymon OL, Savvateeva MV, Melnikova NV, Krasnov GS and Dmitriev AA: ROS Generation and antioxidant defense systems in normal and malignant cells. Oxid Med Cell Longev. 2019:61758042019. View Article : Google Scholar : PubMed/NCBI | |
|
Helfinger V and Schröder K: Redox control in cancer development and progression. Mol Aspects Med. 63:88–98. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Sánchez-Sánchez AM, Martín V, García-Santos G, Rodríguez-Blanco J, Casado-Zapico S, Suarez-Garnacho S, Antolín I and Rodriguez C: Intracellular redox state as determinant for melatonin antiproliferative vs cytotoxic effects in cancer cells. Free Radic Res. 45:1333–1341. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Klaunig JE: Oxidative stress and cancer. Curr Pharm Des. 24:4771–4778. 2018. View Article : Google Scholar | |
|
Xie Q, Lan G, Zhou Y, Huang J, Liang Y, Zheng W, Fu X, Fan C and Chen T: Strategy to enhance the anticancer efficacy of X-ray radiotherapy in melanoma cells by platinum complexes, the role of ROS-mediated signaling pathways. Cancer Lett. 354:58–67. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Galeaz C, Totis C and Bisio A: Radiation resistance: A matter of transcription factors. Front Oncol. 11:6628402021. View Article : Google Scholar : PubMed/NCBI | |
|
Sonis ST: Superoxide dismutase as an intervention for radiation therapy-associated toxicities: Review and profile of avasopasem manganese as a treatment option for radiation-induced mucositis. Drug Des Devel Ther. 15:1021–1029. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Perillo B, Di Donato M, Pezone A, Di Zazzo E, Giovannelli P, Galasso G, Castoria G and Migliaccio A: ROS in cancer therapy: The bright side of the moon. Exp Mol Med. 52:192–203. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Kim SJ, Kim HS and Seo YR: Understanding of ROS-inducing strategy in anticancer therapy. Oxid Med Cell Longev. 2019:53816922019. View Article : Google Scholar | |
|
Hu J, Li Y, Li H, Shi F, Xie L, Zhao L, Tang M, Luo X, Jia W, Fan J, et al: Targeting Epstein-Barr virus oncoprotein LMP1-mediated high oxidative stress suppresses EBV lytic reactivation and sensitizes tumors to radiation therapy. Theranostics. 10:11921–11937. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Poprac P, Jomova K, Simunkova M, Kollar V, Rhodes CJ and Valko M: Targeting free radicals in oxidative stress-related human diseases. Trends Pharmacol Sci. 38:592–607. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Jiang H, Wang H and De Ridder M: Targeting antioxidant enzymes as a radiosensitizing strategy. Cancer Lett. 438:154–164. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Jaganjac M, Milkovic L, Sunjic SB and Zarkovic N: The NRF2, Thioredoxin, and Glutathione system in tumorigenesis and anticancer therapies. Antioxidants (Basel). 9:E11512020. View Article : Google Scholar | |
|
Reczek CR and Chandel NS: The two faces of reactive oxygen species in cancer. Ann Rev Cancer Biol. 1:79–98. 2017. View Article : Google Scholar | |
|
Koyama H, Nojiri H, Kawakami S, Sunagawa T, Shirasawa T and Shimizu T: Antioxidants improve the phenotypes of dilated cardiomyopathy and muscle fatigue in mitochondrial superoxide dismutase-deficient mice. Molecules. 18:1383–1393. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Ighodaro OM and Akinloye OA: First line defence antioxidantssuperoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPX): Their fundamental role in the entire antioxidant defence grid. Alexandria J Med. 54:287–293. 2018. View Article : Google Scholar | |
|
Haddad M, Hervé V, Ben Khedher MR, Rabanel JM and Ramassamy C: Glutathione: An old and small molecule with great functions and new applications in the brain and in Alzheimer's disease. Antioxid Redox Signal. 35:270–292. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Marrocco I, Altieri F and Peluso I: Measurement and clinical significance of biomarkers of oxidative stress in humans. Oxid Med Cell Longev. 2017:65010462017. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang ML, Wu HT, Chen WJ, Xu Y, Ye QQ, Shen JX and Liu J: Involvement of glutathione peroxidases in the occurrence and development of breast cancers. J Transl Med. 18:2472020. View Article : Google Scholar : PubMed/NCBI | |
|
Liu X, Zhang Y, Zhuang L, Olszewski K and Gan B: NADPH debt drives redox bankruptcy: SLC7A11/xCT-mediated cystine uptake as a double-edged sword in cellular redox regulation. Genes Dis. 8:731–745. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Liu J, Xia X and Huang P: xCT: A critical molecule that links cancer metabolism to redox signaling. Mol Ther. 28:2358–2366. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Lu J, Chew EH and Holmgren A: Targeting thioredoxin reductase is a basis for cancer therapy by arsenic trioxide. Proc Natl Acad Sci USA. 104:12288–12293. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Ren X, Zou L, Zhang X, Branco V, Wang J, Carvalho C, Holmgren A and Lu J: Redox signaling mediated by thioredoxin and glutathione systems in the central nervous system. Antioxid Redox Signal. 27:989–1010. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Liu TI, Lu TY, Yang YC, Chang SH, Chen HH, Lu IL, Sabu A and Chiu HC: New combination treatment from ROS-Induced sensitized radiotherapy with nanophototherapeutics to fully eradicate orthotopic breast cancer and inhibit metastasis. Biomaterials. 257:1202292020. View Article : Google Scholar : PubMed/NCBI | |
|
Shevtsov M, Sato H, Multhoff G and Shibata A: Novel approaches to improve the efficacy of immuno-Radiotherapy. Front Oncol. 9:1562019. View Article : Google Scholar : PubMed/NCBI | |
|
Rabus H: Nanodosimetry-on the 'tracks' of biological radiation effectiveness. Z Med Phys. 30:91–94. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Wang H, Jiang H, Van De Gucht M and De Ridder M: Hypoxic radioresistance: Can ROS be the key to overcome it? Cancers (Basel). 11:1122019. View Article : Google Scholar | |
|
Alizadeh E, Orlando TM and Sanche L: Biomolecular damage induced by ionizing radiation: The direct and indirect effects of low-energy electrons on DNA. Annu Rev Phys Chem. 66:379–398. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Baskar R, Dai J, Wenlong N, Yeo R and Yeoh KW: Biological response of cancer cells to radiation treatment. Front Mol Biosci. 1:242014. View Article : Google Scholar : PubMed/NCBI | |
|
Le Caër S: Water Radiolysis: Influence of oxide surfaces on H2 production under ionizing radiation. Water. 3:235–253. 2011. View Article : Google Scholar | |
|
Baldacchino G, Brun E, Denden I, Bouhadoun S, Roux R, Khodja H and Sicard-Roselli C: Importance of radiolytic reactions during high-LET irradiation modalities: LET effect, role of O2 and radiosensitization by nanoparticles. Cancer Nanotechnol. 10:32019. View Article : Google Scholar | |
|
Gong L, Zhang Y, Liu C, Zhang M and Han S: Application of radiosensitizers in cancer radiotherapy. Int J Nanomedicine. 16:1083–1102. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Collin F: Chemical basis of reactive oxygen species reactivity and involvement in neurodegenerative diseases. Int J Mol Sci. 20:24072019. View Article : Google Scholar : | |
|
Dayal R, Singh A, Pandey A and Mishra KP: Reactive oxygen species as mediator of tumor radiosensitivity. J Cancer Res Ther. 10:811–818. 2014. View Article : Google Scholar | |
|
Azzam EI, Jay-Gerin JP and Pain D: Ionizing radiation-induced metabolic oxidative stress and prolonged cell injury. Cancer Lett. 327:48–60. 2012. View Article : Google Scholar | |
|
Robinett ZN, Bathla G, Wu A, Clark JJ, Sibenaller ZA, Wilson T, Kirby P, Allen BG and Hansen MR: Persistent oxidative stress in vestibular schwannomas after stereotactic radiation therapy. Otol Neurotol. 39:1184–1190. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Buonanno M, de Toledo SM, Pain D and Azzam EI: Long-Term consequences of radiation-induced bystander effects depend on radiation quality and dose and correlate with oxidative stress. Radiat Res. 175:405–415. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang QY, Wang FX, Jia KK and Kong LD: Natural product interventions for chemotherapy and radiotherapy-induced side effects. Front Pharmacol. 9:12532018. View Article : Google Scholar : PubMed/NCBI | |
|
Musa AE, Shabeeb D and Alhilfi HSQ: Protective effect of melatonin against radiotherapy-induced small intestinal oxidative stress: Biochemical evaluation. Medicina (Kaunas). 55:3082019. View Article : Google Scholar | |
|
Lei G, Mao C, Yan Y, Zhuang L and Gan B: Ferroptosis, radiotherapy, and combination therapeutic strategies. Protein Cell. 12:836–857. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Liu B, Bhatt D, Oltvai ZN, Greenberger JS and Bahar I: Significance of p53 dynamics in regulating apoptosis in response to ionizing radiation and polypharmacological strategies. Sci Rep. 4:62452014. View Article : Google Scholar | |
|
Zanella F, Link W and Carnero A: Understanding FOXO, new views on old transcription factors. Curr Cancer Drug Targets. 10:135–146. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Schmidt-Ullrich RK, Contessa JN, Lammering G, Amorino G and Lin PS: ERBB receptor tyrosine kinases and cellular radiation responses. Oncogene. 22:5855–5865. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS, et al: Ferroptosis: An iron-dependent form of non-apoptotic cell death. Cell. 149:1060–1072. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Zhu J, Xiong Y, Zhang Y, Wen J, Cai N, Cheng K, Liang H and Zhang W: The molecular mechanisms of regulating oxidative stress-induced ferroptosis and therapeutic strategy in tumors. Oxid Med Cell Longev. 2020:88107852020. View Article : Google Scholar | |
|
Barrera G: Oxidative stress and lipid peroxidation products in cancer progression and therapy. ISRN Oncol. 2012:1372892012.PubMed/NCBI | |
|
Stockwell BR, Jiang X and Gu W: Emerging mechanisms and disease relevance of ferroptosis. Trends Cell Biol. 30:478–490. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Lang X, Green MD, Wang W, Yu J, Choi JE, Jiang L, Liao P, Zhou J, Zhang Q, Dow A, et al: Radiotherapy and immunotherapy promote tumoral lipid oxidation and ferroptosis via synergistic repression of SLC7A11. Cancer Discov. 9:1673–1685. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Li X, Duan L, Yuan S, Zhuang X, Qiao T and He J: Ferroptosis inhibitor alleviates Radiation-induced lung fibrosis (RILF) via down-regulation of TGF-β1. J Inflamm (Lond). 16:112019. View Article : Google Scholar | |
|
Lei G, Zhang Y, Koppula P, Liu X, Zhang J, Lin SH, Ajani JA, Xiao Q, Liao Z, Wang H and Gan B: The role of ferroptosis in ionizing radiation-induced cell death and tumor suppression. Cell Res. 30:146–162. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Li J, Cao F, Yin HL, Huang ZJ, Lin ZT, Mao N, Sun B and Wang G: Ferroptosis: Past, present and future. Cell Death Dis. 11:882020. View Article : Google Scholar : PubMed/NCBI | |
|
Jiang L, Kon N, Li T, Wang SJ, Su T, Hibshoosh H, Baer R and Gu W: Ferroptosis as a p53-mediated activity during tumour suppression. Nature. 520:57–62. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Dodson M, Castro-Portuguez R and Zhang DD: NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis. Redox Biol. 23:1011072019. View Article : Google Scholar : PubMed/NCBI | |
|
Cameron BD, Sekhar KR, Ofori M and Freeman ML: The role of Nrf2 in the response to normal tissue radiation injury. Radiat Res. 190:99–106. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Sekhar KR and Freeman ML: Nrf2 promotes survival following exposure to ionizing radiation. Free Radic Biol Med. 88:268–274. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Feng L, Zhao K, Sun L, Yin X, Zhang J, Liu C and Li B: SLC7A11 regulated by NRF2 modulates esophageal squamous cell carcinoma radiosensitivity by inhibiting ferroptosis. J Transl Med. 19:3672021. View Article : Google Scholar : PubMed/NCBI | |
|
Lippmann J, Petri K, Fulda S and Liese J: Redox modulation and induction of ferroptosis as a new therapeutic strategy in hepatocellular carcinoma. Transl Oncol. 13:1007852020. View Article : Google Scholar : PubMed/NCBI | |
|
Jakobs P, Serbulea V, Leitinger N, Eckers A and Haendeler J: Nuclear factor (Erythroid-Derived 2)-Like 2 and Thioredoxin-1 in atherosclerosis and ischemia/reperfusion injury in the heart. Antioxid Redox Signal. 26:630–644. 2017. View Article : Google Scholar : | |
|
Banning A, Deubel S, Kluth D, Zhou Z and Brigelius-Flohé R: The GI-GPx Gene Is a target for Nrf2. Mol Cell Biol. 25:4914–4923. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Kim YJ, Ahn JY, Liang P, Ip C, Zhang Y and Park YM: Human prx1 gene is a target of Nrf2 and is up-regulated by hypoxia/reoxygenation: Implication to tumor biology. Cancer Res. 67:546–554. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Fisher AB: Peroxiredoxin 6: A Bifunctional enzyme with glutathione peroxidase and phospholipase A2 activities. Antioxid Redox Signal. 15:831–844. 2011. View Article : Google Scholar : | |
|
Yang H, Magilnick N, Lee C, Kalmaz D, Ou X, Chan JY and Lu SC: Nrf1 and Nrf2 regulate rat glutamate-cysteine ligase catalytic subunit transcription indirectly via NF-kappaB and AP-1. Mol Cell Biol. 25:5933–5946. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Sinha K, Das J, Pal PB and Sil PC: Oxidative stress: The mitochondria-dependent and mitochondria-independent pathways of apoptosis. Arch Toxicol. 87:1157–1180. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Chen KW, Demarco B, Heilig R, Shkarina K, Boettcher A, Farady CJ, Pelczar P and Broz P: Extrinsic and intrinsic apoptosis activate pannexin-1 to drive NLRP3 inflammasome assembly. EMBO J. 38:e1016382019. View Article : Google Scholar : PubMed/NCBI | |
|
Cao X, Wen P, Fu Y, Gao Y, Qi X, Chen B, Tao Y, Wu L, Xu A, Lu H and Zhao G: Radiation induces apoptosis primarily through the intrinsic pathway in mammalian cells. Cell Signal. 62:1093372019. View Article : Google Scholar : PubMed/NCBI | |
|
Liu C, Mann D, Sinha UK and Kokot NC: The molecular mechanisms of increased radiosensitivity of HPV-positive oropharyngeal squamous cell carcinoma (OPSCC): An extensive review. J Otolaryngol Head Neck Surg. 47:592018. View Article : Google Scholar : PubMed/NCBI | |
|
Mendes F, Sales T, Domingues C, Schugk S, Abrantes AM, Gonçalves AC, Teixo R, Silva R, Casalta-Lopes J, Rocha C, et al: Effects of X-radiation on lung cancer cells: the interplay between oxidative stress and P53 levels. Med Oncol. 32:2662015. View Article : Google Scholar : PubMed/NCBI | |
|
Mortezaee K, Najafi M, Farhood B, Ahmadi A, Potes Y, Shabeeb D and Musa AE: Modulation of apoptosis by melatonin for improving cancer treatment efficiency: An updated review. Life Sci. 228:228–241. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Qin C, Chen X, Bai Q, Davis MR and Fang Y: Factors associated with radiosensitivity of cervical cancer. Anticancer Res. 34:4649–4656. 2014.PubMed/NCBI | |
|
Kim W, Lee S, Seo D, Kim D, Kim K, Kim E, Kang J, Seong KM, Youn H and Youn B: Cellular stress responses in radiotherapy. Cells. 8:11052019. View Article : Google Scholar : | |
|
Chang HW, Lee M, Lee YS, Kim SH, Lee JC, Park JJ, Nam HY, Kim MR, Han MW, Kim SW and Kim SY: p53-dependent glutamine usage determines susceptibility to oxidative stress in radioresistant head and neck cancer cells. Cell Signal. 77:1098202021. View Article : Google Scholar | |
|
Maya R, Balass M, Kim ST, Shkedy D, Leal JF, Shifman O, Moas M, Buschmann T, Ronai Z, Shiloh Y, et al: ATM-dependent phosphorylation of Mdm2 on serine 395: Role in p53 activation by DNA damage. Genes Dev. 15:1067–1077. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Kim EM, Jung CH, Kim J, Hwang SG, Park JK and Um HD: The p53/p21 complex regulates cancer cell invasion and apoptosis by targeting Bcl-2 family proteins. Cancer Res. 77:3092–3100. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Budanov AV: The role of tumor suppressor p53 in the antioxidant defense and metabolism. Subcell Biochem. 85:337–358. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Rastogi S, Rizwani W, Joshi B, Kunigal S and Chellappan SP: TNF-α response of vascular endothelial and vascular smooth muscle cells involve differential utilization of ASK1 kinase and p73. Cell Death Differ. 19:274–283. 2012. View Article : Google Scholar | |
|
Feltham R, Jamal K, Tenev T, Liccardi G, Jaco I, Domingues CM, Morris O, John SW, Annibaldi A, Widya M, et al: Mind bomb regulates cell death during TNF signaling by suppressing RIPK1's cytotoxic potential. Cell Rep. 23:470–484. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Kokolakis G, Sabat R, Krüger-Krasagakis S and Eberle J: Ambivalent effects of tumor necrosis factor alpha on apoptosis of malignant and normal human keratinocytes. Skin Pharmacol Physiol. 34:94–102. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Stoytcheva ZR and Berry MJ: Transcriptional regulation of mammalian selenoprotein expression. Biochim Biophys Acta. 1790:1429–1440. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Ross MJ, Martinka S, D'Agati VD and Bruggeman LA: NF-kappaB regulates Fas-mediated apoptosis in HIV-associated nephropathy. J Am Soc Nephrol. 16:2403–2411. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Morgan MJ and Liu Z: Crosstalk of reactive oxygen species and NF-κB signaling. Cell Res. 21:103–115. 2011. View Article : Google Scholar | |
|
Li Q, Sun Y, Liu B, Li J, Hao X, Ge W, Zhang X, Bao S, Gong J, Jiang Z, et al: ACT001 modulates the NF-κB/MnSOD/ROS axis by targeting IKKβ to inhibit glioblastoma cell growth. J Mol Med (Berl). 98:263–277. 2020. View Article : Google Scholar | |
|
Kumar S and Clair DS: Radioresistance in prostate cancer: Focus on the interplay between NF-κB and SOD. Antioxidants (Basel). 10:19252021. View Article : Google Scholar | |
|
Soh R, Hardy A and Zur Nieden NI: The FOXO signaling axis displays conjoined functions in redox homeostasis and stemness. Free Radic Biol Med. 169:224–237. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Ponugoti B, Dong G and Graves DT: Role of forkhead transcription factors in diabetes-induced oxidative stress. Exp Diabetes Res. 2012:9397512012. View Article : Google Scholar : PubMed/NCBI | |
|
Yang JY, Xia W and Hu MC: Ionizing radiation activates expression of FOXO3a, Fas ligand, and Bim, and induces cell apoptosis. Int J Oncol. 29:643–648. 2006.PubMed/NCBI | |
|
Lim SW, Jin L, Luo K, Jin J, Shin YJ, Hong SY and Yang CW: Klotho enhances FoxO3-mediated manganese superoxide dismutase expression by negatively regulating PI3K/AKT pathway during tacrolimus-induced oxidative stress. Cell Death Dis. 8:e29722017. View Article : Google Scholar : PubMed/NCBI | |
|
Tseng AH, Wu LH, Shieh SS and Wang DL: SIRT3 interactions with FOXO3 acetylation, phosphorylation and ubiquitinylation mediate endothelial cell responses to hypoxia. Biochem J. 464:157–168. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Wang Y, Chen S and Li H: Hydrogen peroxide stress stimulates phosphorylation of FoxO1 in rat aortic endothelial cells. Acta Pharmacol Sin. 31:160–164. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Guan L, Zhang L, Gong Z, Hou X, Xu Y, Feng X, Wang H and You H: FoxO3 inactivation promotes human cholangiocarcinoma tumorigenesis and chemoresistance through Keap1-Nrf2 signaling. Hepatology. 63:1914–1927. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Araujo J, Breuer P, Dieringer S, Krauss S, Dorn S, Zimmermann K, Pfeifer A, Klockgether T, Wuellner U and Evert BO: FOXO4-dependent upregulation of superoxide dismutase-2 in response to oxidative stress is impaired in spinocerebellar ataxia type 3. Hum Mol Genet. 20:2928–2941. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Rached MT, Kode A, Xu L, Yoshikawa Y, Paik JH, DePinho RA and Kousteni S: FoxO1 is a positive regulator of bone formation by favoring protein synthesis and resistance to oxidative stress in osteoblasts. Cell Metab. 11:147–160. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Ye P, Mimura J, Okada T, Sato H, Liu T, Maruyama A, Ohyama C and Itoh K: Nrf2- and ATF4-dependent upregulation of xCT modulates the sensitivity of T24 bladder carcinoma cells to proteasome inhibition. Mol Cell Biol. 34:3421–3434. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Wang Z: ErbB receptors and cancer. Methods Mol Biol. 1652:3–35. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Valerie K, Yacoub A, Hagan MP, Curiel DT, Fisher PB, Grant S and Dent P: Radiation-induced cell signaling: Inside-out and outside-in. Mol Cancer Ther. 6:789–801. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Appert-Collin A, Hubert P, Crémel G and Bennasroune A: Role of ErbB receptors in cancer cell migration and invasion. Front Pharmacol. 6:2832015. View Article : Google Scholar : PubMed/NCBI | |
|
Wee P and Wang Z: Epidermal growth factor receptor cell proliferation signaling pathways. Cancers (Basel). 9:522017. View Article : Google Scholar | |
|
Rezatabar S, Karimian A, Rameshknia V, Parsian H, Majidinia M, Kopi TA, Bishayee A, Sadeghinia A, Yousefi M, Monirialamdari M and Yousefi B: RAS/MAPK signaling functions in oxidative stress, DNA damage response and cancer progression. J Cell Physiol. Feb 27–2019.Epub ahead of print. View Article : Google Scholar : PubMed/NCBI | |
|
Kim MJ, Choi WG, Ahn KJ, Chae IG, Yu R and Back SH: Reduced EGFR level in eIF2α PhosphorylationDeficient hepatocytes is responsible for susceptibility to oxidative stress. Mol Cells. 43:264–275. 2020.PubMed/NCBI | |
|
Zhang W, Yang H, Zhu L, Luo Y, Nie L and Li G: Role of EGFR/ErbB2 and PI3K/AKT/e-NOS in Lycium barbarum polysaccharides ameliorating endothelial dysfunction induced by oxidative stress. Am J Chin Med. 47:1523–1539. 2019. View Article : Google Scholar | |
|
Boeckx C, Van den Bossche J, De Pauw I, Peeters M, Lardon F, Baay M and Wouters A: The hypoxic tumor microenvironment and drug resistance against EGFR inhibitors: Preclinical study in cetuximab-sensitive head and neck squamous cell carcinoma cell lines. BMC Res Notes. 8:2032015. View Article : Google Scholar : PubMed/NCBI | |
|
Bierl C, Voetsch B, Jin RC, Handy DE and Loscalzo J: Determinants of human plasma glutathione peroxidase (GPx-3) expression. J Biol Chem. 279:26839–26845. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Tonelli C, Chio IIC and Tuveson DA: Transcriptional regulation by Nrf2. Antioxid Redox Signal. 29:1727–1745. 2018. View Article : Google Scholar : | |
|
Kang HJ, Yi YW, Hong YB, Kim HJ, Jang YJ, Seong YS and Bae I: HER2 confers drug resistance of human breast cancer cells through activation of NRF2 by direct interaction. Sci Rep. 4:72012014. View Article : Google Scholar : PubMed/NCBI | |
|
Sakurai A, Nishimoto M, Himeno S, Imura N, Tsujimoto M, Kunimoto M and Hara S: Transcriptional regulation of thioredoxin reductase 1 expression by cadmium in vascular endothelial cells: Role of NF-E2-related factor-2. J Cell Physiol. 203:529–537. 2005. View Article : Google Scholar | |
|
Gordon LI, Burke MA, Singh AT, Prachand S, Lieberman ED, Sun L, Naik TJ, Prasad SV and Ardehali H: Blockade of the erbB2 receptor induces cardiomyocyte death through mitochondrial and reactive oxygen species-dependent pathways. J Biol Chem. 284:2080–2087. 2009. View Article : Google Scholar : | |
|
Allegra AG, Mannino F, Innao V, Musolino C and Allegra A: Radioprotective agents and enhancers factors Preventive and therapeutic strategies for oxidative induced radiotherapy damages in hematological malignancies. Antioxidants (Basel). 9:11162020. View Article : Google Scholar | |
|
Jasek-Gajda E, Jurkowska H, Jasińska M and Lis GJ: Targeting the MAPK/ERK and PI3K/AKT signaling pathways affects NRF2, Trx and GSH antioxidant systems in leukemia cells. Antioxidants (Basel). 9:6332020. View Article : Google Scholar | |
|
Chen QM and Maltagliati AJ: Nrf2 at the heart of oxidative stress and cardiac protection. Physiol Genomics. 50:77–97. 2018. View Article : Google Scholar : | |
|
Qin S, He X, Lin H, Schulte BA, Zhao M, Tew KD and Wang GY: Nrf2 inhibition sensitizes breast cancer stem cells to ionizing radiation via suppressing DNA repair. Free Radic Biol Med. 169:238–247. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Sun X, Wang Q, Wang Y, Du L, Xu C and Liu Q: Brusatol enhances the radiosensitivity of A549 cells by promoting ROS production and enhancing DNA damage. Int J Mol Sci. 17:E9972016. View Article : Google Scholar : PubMed/NCBI | |
|
Lee S, Lim MJ, Kim MH, Yu CH, Yun YS, Ahn J and Song JY: An effective strategy for increasing the radiosensitivity of Human lung Cancer cells by blocking Nrf2-dependent antioxidant responses. Free Radic Biol Med. 53:807–816. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Tsuchida K, Tsujita T, Hayashi M, Ojima A, Keleku-Lukwete N, Katsuoka F, Otsuki A, Kikuchi H, Oshima Y, Suzuki M and Yamamoto M: Halofuginone enhances the chemo-sensitivity of cancer cells by suppressing NRF2 accumulation. Free Radic Biol Med. 103:236–247. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Park M, Kwon J, Shin HJ, Moon SM, Kim SB, Shin US, Han YH and Kim Y: Butyrate enhances the efficacy of radiotherapy via FOXO3A in colorectal cancer patient-derived organoids. Int J Oncol. 57:1307–1318. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Liu Z, Li Y, She G, Zheng X, Shao L, Wang P, Pang M, Xie S and Sun Y: Resveratrol induces cervical cancer HeLa cell apoptosis through the activation and nuclear translocation promotion of FOXO3a. Pharmazie. 75:250–254. 2020.PubMed/NCBI | |
|
Wang H, Bouzakoura S, de Mey S, Jiang H, Law K, Dufait I, Corbet C, Verovski V, Gevaert T, Feron O, et al: Auranofin radiosensitizes tumor cells through targeting thioredoxin reductase and resulting overproduction of reactive oxygen species. Oncotarget. 8:35728–35742. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Xie Q, Zhou Y, Lan G, Yang L, Zheng W, Liang Y and Chen T: Sensitization of cancer cells to radiation by selenadiazole derivatives by regulation of ROS-mediated DNA damage and ERK and AKT pathways. Biochem Biophys Res Commun. 449:88–93. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Liang YW, Zheng J, Li X, Zheng W and Chen T: Selenadiazole derivatives as potent thioredoxin reductase inhibitors that enhance the radiosensitivity of cancer cells. Eur J Med Chem. 84:335–342. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Jia JJ, Geng WS, Wang ZQ, Chen L and Zeng XS: The role of thioredoxin system in cancer: Strategy for cancer therapy. Cancer Chemother Pharmacol. 84:453–470. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Kimple RJ, Vaseva AV, Cox AD, Baerman KM, Calvo BF, Tepper JE, Shields JM and Sartor CI: Radiosensitization of epidermal growth factor receptor/HER2-positive pancreatic cancer is mediated by inhibition of Akt independent of ras mutational status. Clin Cancer Res. 16:912–923. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang S, Fu Y, Wang D and Wang J: Icotinib enhances lung cancer cell radiosensitivity in vitro and in vivo by inhibiting MAPK/ERK and AKT activation. Clin Exp Pharmacol Physiol. May 16–2018.Epub ahead of print. View Article : Google Scholar | |
|
Yi H, Yan X, Luo Q, Yuan L, Li B, Pan W, Zhang L, Chen H, Wang J, Zhang Y, et al: A novel small molecule inhibitor of MDM2-p53 (APG-115) enhances radiosensitivity of gastric adenocarcinoma. J Exp Clin Cancer Res. 37:972018. View Article : Google Scholar : PubMed/NCBI | |
|
Wang J, Wang H and Qian H: Biological effects of radiation on cancer cells. Mil Med Res. 5:202018.PubMed/NCBI | |
|
Desouky O, Ding N and Zhou G: Targeted and non-targeted effects of ionizing radiation. J Radiation Res App Sci. 8:247–254. 2015. | |
|
De Ruysscher D, Niedermann G, Burnet NG, Siva S, Lee AWM and Hegi-Johnson F: Radiotherapy toxicity. Nat Rev Dis Primers. 5:132019. View Article : Google Scholar : PubMed/NCBI | |
|
Mukherjee D, Coates PJ, Lorimore SA and Wright EG: Responses to ionizing radiation mediated by inflammatory mechanisms. J Pathol. 232:289–299. 2014. View Article : Google Scholar | |
|
LeBaron TW, Kura B, Kalocayova B, Tribulova N and Slezak J: A new approach for the prevention and treatment of cardiovascular disorders. Molecular Hydrogen Significantly Reduces the Effects of Oxidative Stress. Molecules. 24:20762019. View Article : Google Scholar : | |
|
Ebrahimi S, Soltani A and Hashemy SI: Oxidative stress in cervical cancer pathogenesis and resistance to therapy. J Cell Biochem. Nov 13–2018.Epub ahead of print. PubMed/NCBI | |
|
Gudkov AV and Komarova EA: The role of p53 in determining sensitivity to radiotherapy. Nat Rev Cancer. 3:117–129. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Li P, Zhao QL, Wu LH, Jawaid P, Jiao YF, Kadowaki M and Kondo T: Isofraxidin, a potent reactive oxygen species (ROS) scavenger, protects human leukemia cells from radiation-induced apoptosis via ROS/mitochondria pathway in p53-independent manner. Apoptosis. 19:1043–1053. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Qin H, Zhang H, Zhang X, Zhang S, Zhu S and Wang H: Resveratrol attenuates radiation enteritis through the SIRT1/FOXO3a and PI3K/AKT signaling pathways. Biochem Biophys Res Commun. 554:199–205. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Nuszkiewicz J, Woźniak A and Szewczyk-Golec K: Ionizing radiation as a source of oxidative stress-the protective role of melatonin and vitamin D. Int J Mol Sci. 21:58042020. View Article : Google Scholar | |
|
Farhood B, Goradel NH, Mortezaee K, Khanlarkhani N, Salehi E, Nashtaei MS, Mirtavoos-Mahyari H, Motevaseli E, Shabeeb D, Musa AE and Najafi M: Melatonin as an adjuvant in radiotherapy for radioprotection and radiosensitization. Clin Transl Oncol. 21:268–279. 2019. View Article : Google Scholar | |
|
Batinic-Haberle I, Tovmasyan A and Spasojevic I: Mn Porphyrin-based redox-active drugs: Differential effects as cancer therapeutics and protectors of normal tissue against oxidative injury. Antioxid Redox Signal. 29:1691–1724. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Batinic-Haberle I, Tovmasyan A, Huang Z, Duan W, Du L, Siamakpour-Reihani S, Cao Z, Sheng H, Spasojevic I and Alvarez Secord A: H2O2-Driven Anticancer Activity of Mn Porphyrins and the underlying molecular pathways. Oxid Med Cell Longev. 2021:66537902021. View Article : Google Scholar |
